Cargando…

Postoperative Fasting Blood Glucose Predicts Prognosis in Stage I-III Colorectal Cancer Patients Undergoing Resection

PURPOSE: The relationship between high blood glucose and colorectal cancer (CRC) has been studied, but the role of postoperative fasting blood glucose (FBG) in patients with a prior normal FBG has never been addressed. METHODS: A total of 120 CRC patients staged I-III were enrolled, and the prognost...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Rui, You, Junhao, Li, Fang, Yan, Bing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7199537/ https://www.ncbi.nlm.nih.gov/pubmed/32382263 http://dx.doi.org/10.1155/2020/2482409

Ejemplares similares

Postoperative serum interleukin-6 levels correlate with survival in stage I-III colorectal cancer
por: Feng, Shouhan, et al.
Publicado: (2023)

A persistent high neutrophil-to-lymphocyte ratio predicts poor prognosis in patients with colorectal cancer undergoing resection
por: Cui, Meiqi, et al.
Publicado: (2020)

Peritoneal recurrence after resection for Stage I–III colorectal cancer: A population analysis
por: Aiken, Taylor, et al.
Publicado: (2022)

Integrated oxidative stress score for predicting prognosis in stage III gastric cancer undergoing surgery
por: Liu, Yu-hang, et al.
Publicado: (2023)

Prognostic Significance of Preoperative Fibrinogen-to-Prealbumin Ratio in Patients with Stage I–III Colorectal Cancer Undergoing Surgical Resection: A Retrospective Cohort Study
por: Hailun Xie,, et al.
Publicado: (2021)

Optimal postoperative surveillance strategies for stage III colorectal cancer
por: Park, Min Young, et al.
Publicado: (2021)

The Impact of Postoperative Complications on Long-Term Oncological Outcomes Following Curative Resection of Colorectal Cancer (Stage I-III): A Systematic Review and Meta-Analysis
por: Mualla, Noor M, et al.
Publicado: (2021)

Frailty is an independent risk factor for recurrence and mortality following curative resection of stage I–III colorectal cancer
por: Mima, Kosuke, et al.
Publicado: (2020)

Role of Chronic Inflammatory Ratios in Predicting Recurrence of Resected Patients with Stage I–III Mucinous Colorectal Adenocarcinoma
por: Liao, Yu-Cui, et al.
Publicado: (2021)

Comprehensive Profiling of Gene Copy Number Alterations Predicts Patient Prognosis in Resected Stages I–III Lung Adenocarcinoma
por: Han, Xiaohong, et al.
Publicado: (2019)

Nomograms incorporated serum direct bilirubin level for predicting prognosis in stages II and III colorectal cancer after radical resection
por: Zhang, Qunfeng, et al.
Publicado: (2016)

Postoperative circulating tumor DNA as markers of recurrence risk in stages II to III colorectal cancer
por: Chen, Gong, et al.
Publicado: (2021)

Prognostic impact of preoperatively elevated and postoperatively normalized carcinoembryonic antigen levels following curative resection of stage I‐III rectal cancer
por: Nakamura, Yuya, et al.
Publicado: (2019)

The difference in prognosis of stage II and III colorectal cancer based on preoperative serum tumor markers
por: You, Weiqiang, et al.
Publicado: (2019)

The Effect of Type 2 Diabetes Mellitus on the Short-Term Outcomes and Prognosis of Stage I–III Colorectal Cancer: A Propensity Score Matching Analysis
por: Cheng, Yong, et al.
Publicado: (2022)

Predictive Value of Postoperative Peripheral CD4+ T Cells Percentage in Stage I–III Colorectal Cancer: A Retrospective Multicenter Cohort Study of 1028 Subjects
por: Li, Zhenhui, et al.
Publicado: (2020)

Construction and Validation of Convenient Clinicopathologic Signatures for Predicting the Prognosis of Stage I-III Gastric Cancer
por: You, Weiqiang, et al.
Publicado: (2022)

Comparison of postoperative plasma D‐dimer levels between patients undergoing laparoscopic resection and conventional open resection for colorectal cancer
por: Kubota, Yawara, et al.
Publicado: (2020)

Interaction between fasting blood glucose and tumor embolus in predicting the postoperative prognosis of 4330 Chinese patients with gastrointestinal tract cancer
por: Hu, Dan, et al.
Publicado: (2020)

Immune cell infiltration as a biomarker for the diagnosis and prognosis of stage I–III colon cancer
por: Zhou, Rui, et al.
Publicado: (2018)

Survival after curative resection for stage I colorectal mucinous adenocarcinoma
por: Huang, Liang, et al.
Publicado: (2022)

Preoperative systemic inflammation predicts postoperative infectious complications in patients undergoing curative resection for colorectal cancer
por: Moyes, L H, et al.
Publicado: (2009)

Prognostic Value of the Lymph Node Ratio in Stage III Gastric Cancer Patients Undergoing Radical Resection
por: Ke, Bin, et al.
Publicado: (2014)

Prognostic value of the preoperative albumin‐bilirubin score among patients with stages I–III gastric cancer undergoing radical resection: A retrospective study
por: Wang, Xiang, et al.
Publicado: (2023)

Utility of circulating tumor cells in stage II colorectal cancer patients undergoing curative resection
por: Yu, Jun-Hui, et al.
Publicado: (2020)

Assessment of the Novel, Practical, and Prognosis-Relevant TNM Staging System for Stage I-III Cutaneous Melanoma
por: Hu, Di, et al.
Publicado: (2022)

Exploring the medication duration based on the effect of traditional Chinese medicine on postoperative stage I-III colorectal patients: a retrospective cohort study
por: Shi, Qi, et al.
Publicado: (2017)

Development and validation of postoperative circulating tumor DNA combined with clinicopathological risk factors for recurrence prediction in patients with stage I-III colorectal cancer
por: Gao, Zhaoya, et al.
Publicado: (2023)

Impact of age on the use of adjuvant treatments in patients undergoing surgery for colorectal cancer: patients with stage III colon or stage II/III rectal cancer
por: Sarasqueta, C., et al.
Publicado: (2019)

Effects of deficient mismatch repair on the prognosis of patients with stage II and stage III colon cancer during different postoperative periods
por: Zhang, Chunze, et al.
Publicado: (2022)

Independent factors FOR poor prognosis in young patients with stage I-III breast cancer
por: Erić, Ivan, et al.
Publicado: (2020)

GALNT14 Genotype Predicts Postoperative Outcome of Stage III Colorectal Cancer With Oxaliplatin as Adjuvant Chemotherapy
por: Lin, Wey-Ran, et al.
Publicado: (2016)

Postoperative prophylactic hepatic arterial infusion chemotherapy for stage III colorectal cancer: a retrospective study
por: Wang, Yao, et al.
Publicado: (2016)

Postoperative, but not preoperative, inflammation-based prognostic markers are prognostic factors in stage III colorectal cancer patients
por: Yasui, Kohei, et al.
Publicado: (2020)

Exploration of predictive biomarkers for postoperative recurrence of stage II/III colorectal cancer using genomic sequencing
por: Kishigami, Fumishi, et al.
Publicado: (2022)

A novel 9-gene signature for the prediction of postoperative recurrence in stage II/III colorectal cancer
por: Xin, Cheng, et al.
Publicado: (2023)

Impact of Postoperative Naples Prognostic Score to Predict Survival in Patients with Stage II–III Colorectal Cancer
por: Park, Su Hyeong, et al.
Publicado: (2023)

Prognostic value of a modified Immunoscore in patients with stage I−III resectable colon cancer
por: Zhao, Ke, et al.
Publicado: (2021)

Prognosis of stage III colorectal carcinomas with FOLFOX adjuvant chemotherapy can be predicted by molecular subtype
por: Kwon, Yujin, et al.
Publicado: (2017)

Intravascular emboli relates to immunosuppressive tumor microenvironment and predicts prognosis in stage III colorectal cancer
por: Song, Xiangping, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vd717lbhbfbehi42bkq9tfdp7n